Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experienceNalinie Joharatnam‐Hogan, Khurum Khan, Valerie Crolley et al.|Therapeutic Advances in Medical Oncology|2020Cited by 37
Abstract B048: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)Khurum Khan, T.R. Jeffry Evans, Uma Mukherjee et al.|Molecular Cancer Therapeutics|2023Cited by 1